Understanding antimicrobial resistance to manage cholera

Agila Kumari Pragasam¹, Veeraraghavan Balaji¹, Ankur Mutreja^{2

3}

Affiliations

¹ Department of Clinical Microbiology, Christian Medical College, Vellore, India.
² Department of Clinical Microbiology, Christian Medical College, Vellore, India. am872@medschl.cam.ac.uk.
³ Department of Medicine, University of Cambridge, Cambridge, UK. am872@medschl.cam.ac.uk.

Agila Kumari Pragasam et al. Nat Microbiol. 2023 Oct.

. 2023 Oct;8(10):1754-1755.

doi: 10.1038/s41564-023-01482-z.

Agila Kumari Pragasam¹, Veeraraghavan Balaji¹, Ankur Mutreja^{2

3}

¹ Department of Clinical Microbiology, Christian Medical College, Vellore, India.
² Department of Clinical Microbiology, Christian Medical College, Vellore, India. am872@medschl.cam.ac.uk.
³ Department of Medicine, University of Cambridge, Cambridge, UK. am872@medschl.cam.ac.uk.

No abstract available

References

1. Mutreja, A. & Dougan, G. Vaccine 38 (Suppl. 1), A46–A51 (2020).
1. Weill, F.-X. et al. Nature 565, 230–233 (2019). - DOI - PubMed - PMC
1. Lassalle, F. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-023-01472-1 (2023). - DOI
1. Mutreja, A. et al. Nature 477, 462–465 (2011). - DOI - PubMed - PMC
1. Ramamurthy, T. et al. Nat. Commun. 13, 3864 (2022). - DOI - PubMed - PMC